COMMUNIQUÉ DE PRESSE

par Bio-Rad Laboratories GmbH (isin : DE0007165607)

EQS-Adhoc: SARTORIUS AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office

EQS-Ad-hoc: SARTORIUS AG / Key word(s): Personnel
SARTORIUS AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office

02-Jul-2024 / 10:47 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosure of inside information according to Article 17 MAR


Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office

The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that, after more than 20 years as CEO, he will not be seeking another contract extension in order to pursue his personal long-term plans. He will fulfill his contract which runs until November 2025 and does not plan to take on an executive top role in another company. The Supervisory Board accepted this decision with great regret and thanked Kreuzburg for his outstanding strategic and operational achievements as well as the increase of the company value by around 180 times since he took office in 2003. A succession process is to be initiated shortly.

 

This notification according to Article 17 MAR contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties. This is a translation of the original German-language announcement. The Sartorius Group shall not assume any liability for the correctness of this translation. The original German ad hoc announcement is the legally binding version. Furthermore, the Sartorius Group reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

 

Göttingen, July 2, 2024

Contact

Petra Kirchhoff

Head of Corporate Communications and Investor Relations

+49 (0)551.308.1686

petra.kirchhoff@sartorius.com

sartorius.com



End of Inside Information

02-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language:English
Company:SARTORIUS AG
Otto-Brenner-Straße 20
37079 Göttingen
Germany
Phone:+49.(0)551-308.0
Fax:+49.(0)551-308.3289
E-mail:info@sartorius.com
Internet:www.sartorius.com
ISIN:DE0007165607, DE0007165631
WKN:716560 , 716563
Indices:DAX, TecDAX
Listed:Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:1937931

 
End of AnnouncementEQS News Service

1937931  02-Jul-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1937931&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6
Voir toutes les actualités de Bio-Rad Laboratories GmbH